Back to RA CAPITAL MANAGEMENT, L.P. RA CAPITAL MANAGEMENT, L.P.

TSHATSHA
Showing 8 of 12 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.RA CAPITAL MANAGEMENT, L.P.'s holdings in TAYSHA GENE THERAPIES INC

RA CAPITAL MANAGEMENT, L.P. holds 23.6M shares of TSHA (TAYSHA GENE THERAPIES INC), worth $160.4M as of 2026-Q2. TSHA represents 1.4% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.

Current Value

$160.4M

Current Shares

23.6M

Total Value Change

+$138.6M

Total Shares Change

+12.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
23.6M
0.0%
$160.4M1.4%$6.81
0
2026-Q1
Unchanged
23.6M
0.0%
$105.3M1.1%$4.53
0
2025-Q4
Unchanged
23.6M
0.0%
$129.6M1.3%$5.66
0
2025-Q3
Unchanged
23.6M
0.0%
$77M0.9%$3.16
0
2025-Q2
Increased
23.6M
+116.7%
$54.4M0.9%$2.38
67
2025-Q1
Unchanged
10.9M
0.0%
$15.1M0.3%$1.93
0
2024-Q4
Unchanged
10.9M
0.0%
$18.8M0.3%$1.73
0
2024-Q3
Unchanged
10.9M
0.0%
$21.9M0.3%$2.07
0

Other major holders of TSHA: Avoro Capital Advisors LLC, GOLDMAN SACHS GROUP INC, BlackRock, Inc., MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used